News from delveinsight business research, llp A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 01, 2023, 11:00 ET Idiopathic Membranous Nephropathy Market to Register Immense Growth at a CAGR of 12% During the Study Period (2019-2032), Predicts DelveInsight

DelveInsight's Idiopathic Membranous Nephropathy Market Insights report includes a comprehensive understanding of current treatment practices,...

May 31, 2023, 11:00 ET CTLA-4 Inhibitors Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 40+ Leading Players Wheeling the Therapeutics Segment

DelveInsight's 'CTLA-4 Inhibitors Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and pipeline...

May 30, 2023, 11:00 ET Parkinson's Disease Market to Exhibit Growth at a CAGR of 11.2% During the Study Period (2019-2032), Assesses DelveInsight

DelveInsight's Parkinson's Disease Market Insights report includes a comprehensive understanding of current treatment practices, Parkinson's disease...

May 29, 2023, 11:00 ET Diabetic Retinopathy Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 50 Key Companies Working in the Domain | DelveInsight

DelveInsight's 'Diabetic Retinopathy Pipeline Insight – 2023' report provides comprehensive global coverage of pipeline diabetic retinopathy...

May 25, 2023, 11:00 ET Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight's 'Idiopathic Pulmonary Fibrosis Pipeline Insight – 2023' report provides comprehensive global coverage of pipeline idiopathic pulmonary ...

May 24, 2023, 11:00 ET Relapsed/Refractory Acute Myeloid Leukemia Market Growing Rapidly, Estimates DelveInsight | Key Companies Active in the Domain - Pfizer, Merck, Novartis, Astellas, Amgen, Janssen, Kartos, Cullinan Oncology, Meryx

DelveInsight's Relapsed/Refractory Acute Myeloid Leukemia Market Insights report includes a comprehensive understanding of current treatment...

May 23, 2023, 11:00 ET DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain

DelveInsight's 'Dry Eye Disease Pipeline Insight – 2023' report provides comprehensive global coverage of pipeline dry eye disease therapies in...

May 22, 2023, 11:00 ET Sickle Cell Disease Market to Observe Impressive Growth, Predicts DelveInsight | Key Companies Active in the Domain - Sanofi, Novartis, Vertex, CRISPR, Vifor, Pfizer, GlaxoSmithKline, Alexion, Global Blood

DelveInsight's Sickle Cell Disease Market Insights report includes a comprehensive understanding of current treatment practices, sickle cell disease...

May 18, 2023, 11:00 ET Glaucoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for the Market Entry

DelveInsight's 'Glaucoma Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and pipeline glaucoma...

May 16, 2023, 11:00 ET Psychosis in Parkinson's and Alzheimer's Disease Market to Observe Stunning Growth at a CAGR of 15.6% in the US During the Study Period (2019-2032), Examines DelveInsight

DelveInsight's Psychosis in Parkinson's and Alzheimer's Disease Market Insights report includes a comprehensive understanding of current treatment...

May 15, 2023, 11:00 ET Smoking Cessation and Nicotine Addiction Market is Projected to Grow at a CAGR of 2.6% During the Study Period (2019-2032) | DelveInsight

DelveInsight's Smoking Cessation and Nicotine Addiction Market Insights report includes a comprehensive understanding of current treatment practices, ...

May 11, 2023, 11:00 ET Cocaine Use Disorder Market to Observe Impressive Growth at a Significant CAGR of 18.1% During the Study Period (2019-2032), Assesses DelveInsight

DelveInsight's Cocaine Use Disorder Market Insights report includes a comprehensive understanding of current treatment practices, cocaine use...

May 10, 2023, 11:00 ET Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain | DelveInsight

DelveInsight's 'Soft Tissue Sarcoma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline soft...

May 09, 2023, 11:00 ET Acute Ischemic Stroke Market is Expected to Showcase Significant Growth at a CAGR of 10.6% During the Study Period (2019-2032), Predicts DelveInsight

DelveInsight's Acute Ischemic Stroke Market Insights report includes a comprehensive understanding of current treatment practices, acute ischemic...

May 09, 2023, 11:00 ET Significant Positive Shift in the Cell and Gene Therapies in Rare Disorders Market with 35.8% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight

DelveInsight's Cell and Gene Therapies in Rare Disorders Market Insights report includes a comprehensive understanding of current treatment...

May 09, 2023, 11:00 ET PD1 and PDL1 Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Incyte Corporation, Bristol-Myers Squibb, Novartis, Bayer, Beigene, Merck, AbbVie, and Others Expected to Propel Market

DelveInsight's PD1 and PDL1 Inhibitors Competitive Landscape report delivers an in-depth understanding of the PD1 and PDL1 inhibitors and the PD1 and ...

May 03, 2023, 11:00 ET Uveitis Market to Witness Upsurge in Growth at a CAGR of 4.8% During the Study Period (2019-2032), Assesses DelveInsight

DelveInsight's Uveitis Market Insights report includes a comprehensive understanding of current treatment practices, uveitis emerging drugs, market...

May 02, 2023, 11:00 ET Obstructive Sleep Apnea Market to Grow Rapidly at a CAGR of 14.7% by 2032, Estimates DelveInsight

DelveInsight's Obstructive Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, obstructive...

May 01, 2023, 11:00 ET Significant Positive Shift in the Glioma Market with 13% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight

DelveInsight's Glioma Market Insights report includes a comprehensive understanding of current treatment practices, glioma emerging drugs, market...

Apr 27, 2023, 11:00 ET Chronic Kidney Disease Market to Observe Impressive Growth at a CAGR of 8.7% by 2032, Estimates DelveInsight

DelveInsight's Chronic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, chronic kidney...

Apr 26, 2023, 11:00 ET Opioid Use Disorder Market to Grow Rapidly at a CAGR of 4.2% by 2032, Predicts DelveInsight

DelveInsight's Opioid Use Disorder Market Insights report includes a comprehensive understanding of current treatment practices, opioid use disorder...

Apr 25, 2023, 11:00 ET FAK Inhibitors Market Growing Rapidly, Estimates DelveInsight | Verastem, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, InxMed are Expected to Contribute to Growth

DelveInsight's FAK Inhibitors Competitive Landscape report delivers an in-depth understanding of the FAK inhibitors and the FAK inhibitors market...

Apr 24, 2023, 11:00 ET Nonalcoholic Steatohepatitis Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Madrigal, Intercept, AstraZeneca, Gilead, Pfizer, Alnylam, Eli Lilly and Company, Novo Nordisk

DelveInsight's Nonalcoholic Steatohepatitis Market Insights report includes a comprehensive understanding of current treatment practices,...

Apr 20, 2023, 11:00 ET Next-Generation Immunotherapies Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Regeneron, Boehringer Ingelheim, Sanofi, AstraZeneca, Roche, Merck, Incyte, GSK, Novartis

DelveInsight's Next-Generation Immunotherapies Competitive Landscape report delivers an in-depth understanding of the next-generation immunotherapies ...

Apr 19, 2023, 11:00 ET Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Working in the Domain | DelveInsight

Parkinson's disease is a progressive disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, ...